Rubius Therapeutics Garners $25,000,000 New Round

  • Feed Type
  • Date
  • Company Name
    Rubius Therapeutics
  • Mailing Address
    620 Memorial Drive Cambridge, MA 02139 USA
  • Company Description
    Rubius is developing a new class of drugs, Red-Cell Therapeutics, for the treatment of a wide array of diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds will enable Rubius to enter clinical testing of its novel therapeutic modality.
  • M&A Terms
  • Venture Investor
    Flagship Ventures

Trending on Xconomy